Xiaoyang Li

Dr. Xiaoyang Li


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2023 in Journal of Medical Systems
Verified
Journal Article
Closed access
PDF file
XWXinyi Wang
Xinyi Wang
ZGZhenye Gong
Zhenye Gong
GWGuoxin Wang
Guoxin Wang
JJJingdan Jia
Jingdan Jia
YXYing Xu
Ying Xu
XLXiaoyang Li
Xiaoyang Li

17 June 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
XQXiaohang Qiao
Xiaohang Qiao
SZSabina Y. van der Zanden
Sabina Y. van der Zanden
DWDennis P. A. Wander
Dennis P. A. Wander
DBDaniel M. Borràs
Daniel M. Borràs
JSJi-Ying Song
Ji-Ying Song
JNJacques Neefjes
Jacques Neefjes
Significance: Anthracyclines like doxorubicin are anticancer drugs, used by over 1 million cancer patients annually. However, they cause severe side effects, most notably, cardiotoxicity and therapy-related malignancies. It is unclear whether these side effects are directly linked to their anticancer activity. Doxorubicin exerts two activities: DNA damage and chromatin damage. Here, we show that both activities conspire in the cardiotoxicity, while doxorubicin variants with only chromatin-damaging activity remain active anticancer drugs devoid of side effects. This challenges the concept that doxorubicin works primarily by inducing DNA double-strand breaks and reveals another major anticancer activity, chromatin damage. Translating these observations will yield anticancer drugs for patients that are currently excluded from doxorubicin treatment and improve the quality of life of cancer survivors.

1 December 2020 in Wilderness & Environmental Medicine
Verified
Journal Article
Closed access
YDYuexin Dong
Yuexin Dong
BDBa Dun
Ba Dun
PDPu Bu Wang Dui
Pu Bu Wang Dui
LMLuo Bu Zhuo Ma
Luo Bu Zhuo Ma
JFJie Fang
Jie Fang
XLXiaoyang Li
Xiaoyang Li
Introduction: High altitude polycythemia (HAPC) is a common chronic disease at high altitudes. It is characterized by excessive erythrocytosis (≥190 g·L-1 in females or ≥210 g·L-1 in males). HAPC severely jeopardizes the health status of plateau dwellers. The Qinghai-Tibet plateau, with an elevation above 4000 m, is the highest plateau in the world. Both Han and Tibetan populations residing there face the threat of HAPC. Therapeutic erythrocytapheresis (TE) was introduced to Tibet as an alternative to phlebotomy in 2015. Methods: In this study, we retrospectively analyzed 155 patients with HAPC treated with TE in Tibet. Routine blood testing values before and after TE were compared to evaluate treatment efficacy. The efficiency rate, defined as the rate of increase in red blood cell depletion attained by TE compared with 450 mL whole blood phlebotomy, was calculated using whole blood volume and hematocrit before and after treatment and used to identify patients who maintained a normal hemoglobin level in the year after the TE procedure. Results: On average, TE reduced red blood cell levels by 1.5×1012·L-1, hemoglobin concentration by 52 g·L-1, and hematocrit by 14% ( P<0.001 for each). Patients who underwent TE with an efficiency rate ≥1.9 were more likely to maintain a normal hemoglobin level in the following year than those who underwent TE with an efficiency rate <1.9 (90 vs 28%, P<0.01). Conclusions: TE is a feasible therapeutic method to treat HAPC on the Qinghai-Tibet plateau. The efficiency rate is a useful tool to predict the expected interval between TE procedures.

25 July 2022 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
PJPeng Jin
Peng Jin
QJQiqi Jin
Qiqi Jin
XWXiaoling Wang
Xiaoling Wang
MZMing Zhao
Ming Zhao
FDFangyi Dong
Fangyi Dong
JLJunmin Li
Junmin Li
Purpose: The molecular complexity of acute myeloid leukemia (AML) presents a considerable challenge to implementation of clinical genetic testing for accurate risk stratification. Identification of better biomarkers therefore remains a high priority to enable improving established stratification and guiding risk-adapted therapy decisions. Experimental Design: We systematically integrated and analyzed the genome-wide CRISPR-Cas9 data from more than 1,000 in vitro and in vivo knockout screens to identify the AML-specific fitness genes. A prognostic fitness score was developed using the sparse regression analysis in a training cohort of 618 cases and validated in five publicly available independent cohorts (n = 1,570) and our RJAML cohort (n = 157) with matched RNA sequencing and targeted gene sequencing performed. Results: A total of 280 genes were identified as AML fitness genes and a 16-gene AML fitness (AFG16) score was further generated and displayed highly prognostic power in more than 2,300 patients with AML. The AFG16 score was able to distill downstream consequences of several genetic abnormalities and can substantially improve the European LeukemiaNet classification. The multi-omics data from the RJAML cohort further demonstrated its clinical applicability. Patients with high AFG16 scores had significantly poor response to induction chemotherapy. Ex vivo drug screening indicated that patients with high AFG16 scores were more sensitive to the cell-cycle inhibitors flavopiridol and SNS-032, and exhibited strongly activated cell-cycle signaling. Conclusions: Our findings demonstrated the utility of the AFG16 score as a powerful tool for better risk stratification and selecting patients most likely to benefit from chemotherapy and alternative experimental therapies.

5 December 2024 in Frontiers in Digital Health
Verified
Journal Article
Open access
PDF file
HJHaijiao Jin
Haijiao Jin
JGJinglu Guo
Jinglu Guo
QLQisheng Lin
Qisheng Lin
SWShaun Wu
Shaun Wu
WHWeiguo Hu
Weiguo Hu
XLXiaoyang Li
Xiaoyang Li
Background: The rapid development of artificial intelligence (AI) has shown great potential in medical document generation. This study aims to evaluate the performance of Claude 3.5-Sonnet, an advanced AI model, in generating discharge summaries for patients with renal insufficiency, compared to human physicians.Methods: A prospective, comparative study was conducted involving 100 patients (50 with acute kidney injury and 50 with chronic kidney disease) from the nephrology department of Ningbo Hangzhou Bay Hospital between January and June 2024. Discharge summaries were independently generated by Claude 3.5-Sonnet and human physicians. The main evaluation indicators included accuracy, generation time, and overall quality.Results: Claude 3.5-Sonnet demonstrated comparable accuracy to human physicians in generating discharge summaries for both AKI (90 vs. 92 points, p > 0.05) and CKD patients (88 vs. 90 points, p > 0.05). The AI model significantly outperformed human physicians in terms of efficiency, requiring only about 30 s to generate a summary compared to over 15 min for physicians (p < 0.001). The overall quality scores showed no significant difference between AI-generated and physician-written summaries for both AKI (26 vs. 27 points, p > 0.05) and CKD patients (25 vs. 26 points, p > 0.05).Conclusion: Claude 3.5-Sonnet demonstrates high efficiency and reliability in generating discharge summaries for patients with renal insufficiency, with accuracy and quality comparable to those of human physicians. These findings suggest that AI has significant potential to improve the efficiency of medical documentation, though further research is needed to optimize its integration into clinical practice and address ethical and privacy concerns.

16 February 2023 in Research Square
Verified
Preprint
Open access
PDF file
XWXinyi Wang
Xinyi Wang
ZGZhenye Gong
Zhenye Gong
GWGuoxin Wang
Guoxin Wang
JJJingdan Jia
Jingdan Jia
YXYing Xu
Ying Xu
XLXiaoyang Li
Xiaoyang Li
INTRODUCTION: ChatGPT, a language model developed by OpenAI, uses a 175 billion parameter Transformer architecture for natural language processing tasks. This study aimed to compare the knowledge and interpretation ability of ChatGPT with those of medical students in China by administering the Chinese National Medical Licensing Examination (NMLE) to both ChatGPT and medical students. METHODS We evaluated the performance of ChatGPT in two years' worth of the NMLE, which consists of four units. At the same time, the exam results were compared to those of medical students who had studied for five years at medical colleges. RESULTS ChatGPT’s performance was lower than that of the medical students, and ChatGPT’s correct answer rate was related to the year in which the exam questions were released. CONCLUSION ChatGPT’s knowledge and interpretation ability for the NMLE were not yet comparable to those of medical students in China. It is probable that these abilities will improve through deep learning.